NASDAQ · INVA

Innoviva, Inc.

$21.44 +$0.24 (+1.13%) 1D After hours
Charting by TradingView

Key Metrics

$1.56B
Market cap
6.71×
P/E · TTM
$9.36M
Revenue · TTM
$233.18M
Net income
EPS · TTM $3.72
Dividend yield —
Free cash flow —
Beta · 1Y -0.04
EBITDA · TTM —
Gross margin 26.9%

Snapshot

Market cap$1.56B
Enterprise value$806.68M
Shares outstanding73.8M
52-wk range$16.52 – $25.15
Avg volume · 20D731.4K
Net cash $758.07M
Book value / share$21.39
IndustryPharmaceutical Preparations
ExchangeNASDAQ
About Innoviva, Inc.
IPO dateOct 5, 2004
Employees159

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E6.71
P/S167.14
P/FCF—
EV/EBITDA—
EV/Sales86.17
Graham №$42.31

Profitability

Gross 26.9%
Operating 2,917.7%
Net 2,490.7%
FCF —
ROE / ROIC 17.4% · —

Financial Health

Current ratio21.13
Quick ratio20.07
Debt / equity0.19
Debt / EBITDA —
Net cash $758.07M
Working capital$736.07M

Cash Flow · TTM

Operating CF —
Capex —
Free cash flow —
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

$42.31 vs $21.44
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings